Hepatitis C Virus and the Infectious Diseases Community

Holmberg, Scott D.
July 2012
Clinical Infectious Diseases;Jul2012 Supplement 1, Vol. 55 Issue suppl_1, pS1
Academic Journal
The article focuses on the prevalence of hepatitis C virus infection in the U.S. It discusses several causes of infection which includes parenteral exposures, injection drug use and transfusions. It explores that the quality of laboratory tests in the U.S. is improving in their speed, reliability and specificity which are used for the detection of middle-aged HIV infections.


Related Articles

  • parenteral.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1713 

    A definition of the term "parenteral" which refers to any medication route aside from the alimentary canal is presented.

  • parenteral therapy.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1713 

    A definition of the term "parenteral therapy" which refers to a medicine or solution that is administered by means of a route aside from ingestion is presented.

  • Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users. Backmund, Markus; Meyer, Kirsten; Edlin, Brian R. // Clinical Infectious Diseases;11/15/2004, Vol. 39 Issue 10, p1540 

    We followed-up 18 injection drug users for a mean of 33.8 months (range, 4-55 months) after successful treatment for hepatitis C virus (HCV) infection. Fifteen (83%) of the patients remained HCV RNA-negative, 1 patient was not tested, and 2 patients had test results positive for HCV RNA. The...

  • THE SUBTLE ART OF REALLY GOOD INJECTIONS. McConnell, Edwina A. // RN;Feb82, Vol. 45 Issue 2, p24 

    Presents a guide to parenteral injections. Criteria for selecting the ideal needle; Tips on choosing and evaluating the injection site; Advice on holding trauma to an absolute minimum.

  • Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. Rao, Malla R.; Naficy, Abdollah B.; Darwish, Medhat A.; Darwish, Nebal M.; Schisterman, Enrique; Clemens, John D.; Edelman, Robert // BMC Infectious Diseases;2002, Vol. 2 Issue 1, p29 

    Background: Hepatitis C virus (HCV) infection and schistosomiasis are major public health problems in the Nile Delta of Egypt. To control schistosomiasis, mass treatment campaigns using tartar emetic injections were conducted in the 1960s through 1980s. Evidence suggests that inadequately...

  • Parenteral drug administration errors by nursing staff on an acute medical admissions ward during day duty. Bruce, J.; Wong, I. // Drug Safety;Aug2001, Vol. 24 Issue 11, p855 

    Background: Parenteral therapy is a route of administration for drugs which are poorly absorbed via the oral route and it can provide a rapid response during an emergency. However, poorly prepared and/or administered parenteral therapy can cause potential harm to patients such as...

  • Treatment for Hepatitis C Virus Infection among Current Injection Drug Users in Australia. Matthews, Gail; Kronborg, Ian J.; Dore, Gregory J. // Clinical Infectious Diseases;4/15/2005 Supplement, Vol. 40, pS325 

    An estimated 210,000 people were living with hepatitis C virus (HCV) infection in Australia at the end of 2001, and the number of people developing cirrhosis was projected to increase 4-fold by 2020. Eighty percent of prevalent and 90% of incident HCV infections are related to injection drug...

  • DRUG PARAPHERNALIA LAWS AND INJECTION-RELATED INFECTIOUS DISEASE RISK AMONG DRUG INJECTORS. Bluthenthal, Ricky N.; Kral, Alex H.; Erringer, Elizabeth A.; Edlin, Brian R. // Journal of Drug Issues;Winter99, Vol. 29 Issue 1, p1 

    The article reports on the injection drug users (IDUs) and related diseases among drug injectors. The IDUs are considered to be at major risk for infection with human immunodeficiency virus (HIV) and other related diseases. These diseases include hepatitis B virus and hepatitis C virus. The...

  • Knowledge and Attitudes about Treatment for Hepatitis C Virus Infection and Barriers to Treatment among Current Injection Drug Users in Australia. Doab, Anna; Treloar, Carla; Dore, Gregory J. // Clinical Infectious Diseases;4/15/2005 Supplement, Vol. 40, pS313 

    Despite recent improvements in outcomes of treatment for infection with hepatitis C virus (HCV), very few current injection drug users (IDUs) have access to treatment programs. We examined the natural history of and treatment knowledge about HCV infection and barriers and willingness to seek...


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics